News Content
In the medical treatment setting, it is a cornerstone drug for breast cancer treatment. For patients with estrogen receptor-positive breast cancer, Nolvadex competitively binds to estrogen receptors in breast tissue, blocking the "nurturing" effects of estrogen on cancer cells. Clinical data show that continuous use for five years after surgery can reduce the risk of breast cancer recurrence by 40% and the risk of distant metastasis by 30%. It is particularly effective in premenopausal women. It is also used to prevent breast cancer in high-risk groups (such as those with a family history of the disease) and to treat hormone-related conditions such as dysfunctional uterine bleeding and endometriosis.
In the context of fitness and hormone regulation, it's a crucial tool for "anti-estrogen and testicular protection." When testosterone-based steroids increase estrogen levels in fitness enthusiasts, leading to side effects such as breast development (mast pain, lumps), and water and sodium retention, a daily dose of 20-40mg of Nolvadex can alleviate these symptoms by inhibiting estrogen activity in breast tissue. It also stimulates the pituitary gland to secrete gonadotropins, reducing the steroid's suppression of testosterone production. Studies have shown that using Nolvadex after a steroid cycle can shorten endogenous testosterone recovery time by 30%-40%, reducing the risk of muscle loss.
It's important to clarify that Nolvadex is not a steroid and has no direct effect on muscle growth or athletic performance. Long-term use may pose risks such as blood clots and endometrial hyperplasia. Medical experts emphasize: "Its value lies in 'precision regulation,' not 'performance enhancement.' Whether for treatment or fitness assistance, it should be used appropriately under professional guidance and based on individual hormone levels to avoid indiscriminate abuse."
